Today Dr. Robert Nagourney discusses treatment options for Triple Negative Breast Cancer, which accounts for 10 to 15 percent of all breast cancers and tends to grow and spread faster than other breast cancers.

Dr. Robert Nagourney today discusses an important presentation conducted at an American Association for Cancer Research Special Conference on Pancreatic Cancer.

Today Dr. Nagourney discusses the management of breast cancer, specifically HER2-positive breast cancer, and visits with a patient who has a remarkable story and shares her experience.

Vitamin C truly may be an excellent option for fighting cancer. It is increasingly evident that Vitamin C, known for its antioxidant properties, can also function as a “pro-oxidant”. Pro-oxidants introduce higher levels of toxic free radicals into their surroundings which can cause both harm and therapeutic benefit.

Dr. Nagourney turns detective today as he deciphers and ultimately exposes the herbal treatment PC-SPES for prostate cancer as non-herbal. But he has not given up that some herbal agents may be helpful in cancer treatment and prevention.

Dr. Nagourney today examines the options for bladder cancer and the potential for a new class of drugs. 

Dr. Nagourney discusses the development of drug resistance in colon cancer patients that contributed to the failure of the oxaliplatin-based HIPEC PRODIGE 7 Trial

Dr. Nagourney discusses treatment of pancreatic cancer and options while interviewing a patient with cancer of the pancreas.

Today Dr. Nagourney will be examining what medical oncologists do and how they do It.